Feb 28
|
United Therapeutics price target lowered to $420 from $430 at Leerink
|
Feb 27
|
United Therapeutics Corp (UTHR) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ...
|
Feb 27
|
Q4 2024 United Therapeutics Corp Earnings Call
|
Feb 26
|
Why United Therapeutics (UTHR) Stock Is Down Today
|
Feb 26
|
United Therapeutics Stock Down Despite Q4 Earnings & Sales Beat
|
Feb 26
|
United Therapeutics (UTHR) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
|
Feb 26
|
United Therapeutics (NASDAQ:UTHR) Reports Q4 In Line With Expectations
|
Feb 26
|
United Therapeutics (UTHR) Surpasses Q4 Earnings and Revenue Estimates
|
Feb 26
|
United Therapeutics: Q4 Earnings Snapshot
|
Feb 26
|
United Therapeutics Corporation Reports Fourth Quarter and Full Year 2024 Financial Results
|
Feb 25
|
What To Expect From United Therapeutics’s (UTHR) Q4 Earnings
|
Feb 24
|
Seeking Clues to United Therapeutics (UTHR) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics
|
Feb 24
|
United Therapeutics Corporation to Present at the TD Cowen 45th Annual Health Care Conference
|
Feb 23
|
United Therapeutics Corporation (UTHR): Among Renaissance Technologies Portfolio’s Top Stock Picks
|
Feb 19
|
United Therapeutics Corporation to Report Fourth Quarter and Full Year 2024 Financial Results Before the Market Opens on Wednesday, February 26, 2025
|
Feb 14
|
United Therapeutics (UTHR): Buy, Sell, or Hold Post Q3 Earnings?
|
Feb 13
|
Strength Seen in United Therapeutics (UTHR): Can Its 4.9% Jump Turn into More Strength?
|
Feb 13
|
Ardelyx (ARDX) Earnings Expected to Grow: Should You Buy?
|
Feb 12
|
United Therapeutics Corporation (UTHR): A Cheap Biotech Stock to Invest In Now
|
Sep 24
|
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the CHEST 2024 Annual Meeting
|